Skip to content

Dynamic CT Perfusion for Functional Assessment of Coronary Artery Disease

Multicenter Diagnostic Performance of Dynamic CT Perfusion for Functional Assessment of Coronary Artery Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04712513
Enrollment
240
Registered
2021-01-15
Start date
2021-03-31
Completion date
2024-03-31
Last updated
2021-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Computed Tomography, Myocardial Perfusion, Fractional Flow Reserve

Brief summary

The objective of this multicenter study is to evaluate the diagnostic accuracy of dynamic cardiac CT perfusion (CTP) imaging for non-invasive functional assessment of coronary artery disease (CAD). The proposed CTP technique allows concomitant assessment of two imaging-derived cardiac biomarkers including fractional flow reserve (FFR) and myocardial perfusion from a single dynamic imaging sequence, which facilities simultaneous evaluation of the hemodynamics in epicardial coronary arteries and coronary microcirculation in patients with CAD. The CTP results will be compared with invasive coronary angiography / FFR assessment and non-invasive cardiac magnetic resonance imaging (CMR) / radionuclide perfusion assessment.

Interventions

DIAGNOSTIC_TESTDynamic cardiac CT perfusion imaging

Multiple images of the heart are acquired with a clinical CT scanner after an intravenous bolus injection of contrast solution. The images are then analyzed to provide fractional flow reserve and myocardial perfusion values.

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
London Health Sciences Centre
CollaboratorOTHER
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Subject Inclusion Criteria Patients need to meet all the following inclusion criteria to be enrolled in the study: 1. Symptomatic and hemodynamically stable 2. Acute coronary syndrome (ACS) ruled out based on absence of abnormal changes in ECG and cardiac enzymes 3. Referral for cardiac catheterization based on clinical history and non-invasive imaging test findings. Non-invasive imaging findings include one or more of the following: (i) Evidence of myocardial ischemia from radionuclide myocardial perfusion imaging; (ii) Evidence of myocardial ischemia from CMR myocardial perfusion imaging; (iii) Evidence of ≥ 50% stenosis in the left circumflex artery (LCx), left anterior descending artery (LAD) and/or right coronary artery (RCA) from CCTA. 4. Ability to undergo stress myocardial perfusion test (absence of contraindications for vasodilator) 5. Written informed consent 2. Subject

Exclusion criteria

Patients meeting at least one of the following criteria will be excluded from the study: 1. Recent (\< 1 month) ACS 2. CCTA reveals ≥ 50% stenosis in the left main artery 3. Severe chronic kidney disease (CKD) with estimated glomerular filtration rate (eGFR) \< 30 mL/min/1.73m2 4. Contraindications to stress perfusion imaging, including: i) severe reactive airway disease; ii) high-grade atrioventricular block; iii) allergy to vasodilators; iv) caffeine within 12 hours; v) theophylline use within 48 hours. 5. History of CABG surgery 6. History of malignancy during the past 3 years prior to screening 7. History of alcohol and/or drug abuse within 3 years prior to screening 8. Sign of pregnancy 9. Pregnant or nursing 10. History of severe allergic or anaphylactic reaction to any allergen including drugs and contrast agents 11. Recent (\< 1 month) use of an investigational drug or device 12. Participation in any other investigational drug or device trial during the conduct of this study 13. Lack of ability or willingness to comply with the protocol requirements or deemed by the Site Investigator to be unfit for the study

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of FFR obtained from dynamic cardiac CT perfusion imaging for detecting functionally significant coronary artery stenosisWithin 4 weeks prior to invasive cardiac catheterizationComparison with invasive coronary angiography and FFR assessment
Comparison of diagnostic accuracy for functional CAD assessment between dynamic CT perfusion and static CT perfusionWithin 4 weeks prior to invasive cardiac catheterizationComparison in patients with multi-vessel CAD where balanced ischemia is expected
Comparison of diagnostic accuracy for functional CAD assessment between dynamic CT perfusion and CT-FFR (based on computational fluid dynamics simulation)Within 4 weeks prior to invasive cardiac catheterizationComparison in patients with dense coronary calcification
Accuracy of myocardial perfusion obtained from dynamic cardiac CT perfusion imaging for detecting functionally significant coronary artery stenosisWithin 4 weeks prior to invasive cardiac catheterizationComparison with invasive coronary angiography and FFR assessment
Accuracy of combined myocardial perfusion and FFR measurement obtained from dynamic cardiac CT perfusion imaging for detecting functionally significant coronary artery stenosisWithin 4 weeks prior to invasive cardiac catheterizationComparison with invasive coronary angiography and FFR assessment

Secondary

MeasureTime frameDescription
Comparison of diagnostic accuracy of dynamic CT perfusion for functional CAD assessment between male and female patientsWithin 4 weeks prior to invasive cardiac catheterizationSex-based analysis
Comparison of diagnostic accuracy for functional CAD assessment between dynamic CT perfusion and other non-CT perfusion imaging techniquesWithin 4 weeks of the acquisition of non-CT perfusion imagingComparison with CMR / radionuclide perfusion assessment

Countries

Canada

Contacts

Primary ContactAaron So, PhD
aso@robarts.ca(519)9315777

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026